Tp-e interval

1. Dapagliflozin decreases Tp-e interval in humans (-6.2 ms, p < .001).

   Human trialtype 2 diabetes mellitus3 monthsn = 700

   Effect of dapagliflozin on electrocardiographic arrhythmic markers in patients with type 2 diabetes mellitus · British journal of clinical pharmacology · 13 Sep 2026

Dapagliflozin →